Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KOSELUGO safely and effectively. See full prescribing information for KOSELUGO.KOSELUGO® (selumetinib) capsules, for oral useKOSELUGO® (selumetinib) oral granulesInitial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
KOSELUGO is indicated for the treatment of pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) [see Dosage and Administration (2)].
- generic_name
- selumetinib
- product_names
- SELUMETINIB
- ndc
- 0310-0610, 0310-0610-60, 0310-0610-28, 0310-0625, 0310-0625-60, 0310-0625-28, 0310-0635, 0310-0635-60, 0310-0640, 0310-0640-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en